AFAP1L2 enables SH3 domain binding activity and protein tyrosine kinase activator activity and is involved in the positive regulation of the epidermal growth factor receptor signaling pathway, associated with vesicoureteral reflux and cartilage cancer [36]. This evidence concerns the gene AFAP1L2 and vesicoureteral reflux.